BF
BioForce Nanosciences Holdings, Inc.
BFNH · OTC
$10.01 +6.68% (+$0.63)
1M +143.59%
Market Cap $305.3M
P/E Ratio -
Div. Yield -
ROE 84.02%
Bulios Fair Price
$7.18
28.3% downside
Current Price
$10.01
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BFNH is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 132.55x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 26.65%
ROE 84.02%
ROA 4.08%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 25.41x
Int. coverage N/A
Stability
18 /100
Unstable Beta -0.43x
EPS volatility 75.65%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BFNH
Online
Sector
Consumer Defensive
Industry
Packaged Foods
CEO
Richard James Kaiser
Employees
3
Headquarters
Virginia Beach